rs1139538
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000462091.5(UMPS):n.-28A>G variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.584 in 1,612,770 control chromosomes in the GnomAD database, including 277,549 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.55 ( 23578 hom., cov: 32)
Exomes 𝑓: 0.59 ( 253971 hom. )
Consequence
UMPS
ENST00000462091.5 non_coding_transcript_exon
ENST00000462091.5 non_coding_transcript_exon
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.35
Publications
21 publications found
Genes affected
UMPS (HGNC:12563): (uridine monophosphate synthetase) This gene encodes a uridine 5'-monophosphate synthase. The encoded protein is a bifunctional enzyme that catalyzes the final two steps of the de novo pyrimidine biosynthetic pathway. The first reaction is carried out by the N-terminal enzyme orotate phosphoribosyltransferase which converts orotic acid to orotidine-5'-monophosphate. The terminal reaction is carried out by the C-terminal enzyme OMP decarboxylase which converts orotidine-5'-monophosphate to uridine monophosphate. Defects in this gene are the cause of hereditary orotic aciduria. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Mar 2010]
UMPS Gene-Disease associations (from GenCC):
- orotic aciduriaInheritance: AR, AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 3-124730444-A-G is Benign according to our data. Variant chr3-124730444-A-G is described in ClinVar as Benign. ClinVar VariationId is 100126.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.659 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| UMPS | ENST00000232607.7 | c.-28A>G | upstream_gene_variant | 1 | NM_000373.4 | ENSP00000232607.2 |
Frequencies
GnomAD3 genomes AF: 0.549 AC: 83484AN: 151940Hom.: 23564 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
83484
AN:
151940
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.606 AC: 152139AN: 251240 AF XY: 0.606 show subpopulations
GnomAD2 exomes
AF:
AC:
152139
AN:
251240
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.588 AC: 858625AN: 1460710Hom.: 253971 Cov.: 51 AF XY: 0.589 AC XY: 427604AN XY: 726566 show subpopulations
GnomAD4 exome
AF:
AC:
858625
AN:
1460710
Hom.:
Cov.:
51
AF XY:
AC XY:
427604
AN XY:
726566
show subpopulations
African (AFR)
AF:
AC:
13704
AN:
33446
American (AMR)
AF:
AC:
32630
AN:
44706
Ashkenazi Jewish (ASJ)
AF:
AC:
15874
AN:
26120
East Asian (EAS)
AF:
AC:
25108
AN:
39666
South Asian (SAS)
AF:
AC:
52744
AN:
86222
European-Finnish (FIN)
AF:
AC:
28194
AN:
53352
Middle Eastern (MID)
AF:
AC:
3296
AN:
5474
European-Non Finnish (NFE)
AF:
AC:
651729
AN:
1111408
Other (OTH)
AF:
AC:
35346
AN:
60316
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
18013
36026
54039
72052
90065
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
17934
35868
53802
71736
89670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.549 AC: 83539AN: 152060Hom.: 23578 Cov.: 32 AF XY: 0.552 AC XY: 41034AN XY: 74334 show subpopulations
GnomAD4 genome
AF:
AC:
83539
AN:
152060
Hom.:
Cov.:
32
AF XY:
AC XY:
41034
AN XY:
74334
show subpopulations
African (AFR)
AF:
AC:
17403
AN:
41484
American (AMR)
AF:
AC:
10249
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
AC:
2116
AN:
3472
East Asian (EAS)
AF:
AC:
3391
AN:
5152
South Asian (SAS)
AF:
AC:
2988
AN:
4810
European-Finnish (FIN)
AF:
AC:
5498
AN:
10558
Middle Eastern (MID)
AF:
AC:
174
AN:
294
European-Non Finnish (NFE)
AF:
AC:
40040
AN:
67972
Other (OTH)
AF:
AC:
1244
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
1947
3893
5840
7786
9733
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
720
1440
2160
2880
3600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2179
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2Other:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
-
Diasio Lab, Mayo Clinic
Significance:not provided
Review Status:no classification provided
Collection Method:literature only
- -
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Oroticaciduria Benign:2
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.